Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
IBRX
#815
ImmunityBio, Inc. Common Stock
9.7
8
+3.93%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+3.93%
Aylık değişim
+63.00%
6 aylık değişim
+312.66%
Yıllık değişim
+213.46%
Önceki kapanış
9.4
1
Open
9.7
8
Bid
Ask
Low
9.7
8
High
9.7
8
Hacim
189
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
IBRX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
109.34 M
397.91 M
435.84 M
673.95 M
853.44 M
1.03 B
—
Valuation ratios
Enterprise value
—
2.24 B
1.98 B
3.27 B
2.04 B
1.95 B
9.27 B
Price to earnings ratio
—
-6.83
-4.59
-4.56
-4.13
-5.21
-22.26
Price to sales ratio
—
2 533.77
7 948.02
4 284.97
121.61
16.08
155.25
Price to cash flow ratio
—
-8.62
-5.65
-7.27
-4.58
-5.97
-24.09
Price to book ratio
—
9.77
4.26
4.54
3.67
3.64
6.31
Enterprise value to EBITDA ratio
—
—
—
—
-6.25
25.23
-301.82
Profitability ratios
Return on assets %
0.61
0.74
1.15
1.16
1.08
0.7
0.91
Return on equity %
0.79
1.42
0.93
1
0.85
0.7
0.63
Return on invested capital %
406.3
499.16
255.34
327.6
630.3
482.51
477.01
Gross margin %
100
100
100
100
100
99.34
397.58
Operating margin %
82.55 K
35.36 K
146.37 K
58.24 K
2 334.23
226
1 002.3
EBITDA margin %
—
—
—
—
-2 215.18
68.17
308.16
Net margin %
83.23 K
37.13 K
173.57 K
93.76 K
2 804.77
310.18
1 506.74
Liquidity ratios
Quick ratio
—
—
—
—
3.21
5.08
16.76
Current ratio
3.06
0.91
0.28
5.05
3.36
5.1
17.19
Inventory turnover
—
—
—
—
0
0.16
0.15
Asset turnover
0
0
0
0
0.03
0.26
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
-0.18
1.66
0.74
0.65
2.99
Long term debt to total equity ratio
—
—
-0.14
1.43
0.58
0.65
2.29
Per share metrics
Operating cash flow per share
—
0.7
0.84
0.72
0.56
0.33
0.34
EBIT per share
—
—
—
—
-0.49
0.07
0.08
EBITDA per share
—
—
—
—
-0.47
0.08
0.1
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
0.81
0.27
0.52
0.21
0.26
0.78
Net current asset value per share
—
0.86
0.35
0.58
0.26
0.34
1.05
Tangible book value per share
—
0.62
1.07
1.12
0.68
0.53
2.37
Working capital per share
—
-0.09
-0.9
0.46
0.19
0.28
0.81
Book value per share
—
0.62
1.12
1.15
0.7
0.54
2.43
Haberler
Simon, director, sells ImmunityBio (IBRX) shares worth $900k
ImmunityBio mesane kanseri denemesinde kaydı tamamladı
ImmunityBio completes enrollment in bladder cancer trial
ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)
Netflix and Palantir among market cap stock movers on Wednesday
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)
ImmunityBio’nun Selecky’si 250.000 dolar değerinde hisse sattı
Simon, Barry J. ImmunityBio (IBRX) hisselerini 1,78 milyon dolara sattı
AMD and Keysight Technologies among market cap stock movers on Tuesday
Tesla, Oracle among market cap stock movers on Monday
H.C. Wainwright, Immunitybio hisse hedefini 15 dolara yükseltti
H.C. Wainwright raises Immunitybio stock price target to $15